Gallery
- PM Modi visit USAOnly the mirror in my washroom and phone gallery see the crazy me : Sara KhanKarnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)
Freya Deshmane riding on Reinroe Adare Acrobat claimed the top spot and clinched the gold
- Salah sets Premier League record in Liverpool's draw at Newcastle
- India Open Competition in Shotgun begins in Jaipur, paving way for Nationals' qualification
- Hockey India names Amir Ali-led 20-man team for Junior Asia Cup
- Harmanpreet Singh named FIH Player of the Year, PR Sreejesh gets best goalkeeper award
- World Boxing medallist Gaurav Bidhuri to flag off 'Delhi Against Drugs' movement on Nov 17
Moderna to make up to 125 million Covid vaccine doses available globally Last Updated : 04 Dec 2020 08:42:11 PM IST Moderna US-based drugmaker Moderna has said that it expects to have between 100 million and 125 million doses of its experimental vaccine ' title=' Covid vaccine '>Covid vaccine available globally in the first quarter of 2021.
Out of these, about 85-100 million doses will be made available in the US and 15-25 million doses will be available outside of the US, the company said on Thursday.These expected first quarter doses are inclusive within the 500 million to up to one billion doses that the company expects to manufacture globally in 2021.Moderna also re-affirmed its expectation of having approximately 20 million doses available in the US by the end of this year.The development comes after the company's November 30 announcement that the primary efficacy analysis of the Phase 3 study of the "mRNA-1273" vaccine showed efficacy of 94.1 per cent.Also on November 30, Moderna submitted a request for an emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) and conditional approval from the European Medicines Agency (EMA).Apart from Moderna, drug makers Pfizer and BioNTech also applied for emergency authorisation of their Covid-19 vaccine from the US FDA.Britain on Wednesday approved the emergency use of the Pfizer-BioNTech Covid-19 vaccine from next week.IANS New York For Latest Updates Please-
Join us on
Follow us on
172.31.16.186